Skip to main content
Erschienen in: Journal of Mammary Gland Biology and Neoplasia 1/2013

01.03.2013 | Preface

Preface

verfasst von: Mary Beth Martin

Erschienen in: Journal of Mammary Gland Biology and Neoplasia | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

Over the past several decades, the global incidence rate of breast cancer has increased continuously [14] with the most rapid increase occurring in economically developing countries [4]. In 2008, approximately 1.3 million new cases of breast cancer were diagnosed, accounting for 23 % of all cancers [3] and making breast cancer the most commonly diagnosed cancer in women [3, 5]. Approximately, 55 % of breast cancer cases were diagnosed in developed countries and the remaining 45 % of the cases were diagnosed in developing countries [3]. Although breast cancer is the most common cancer in women worldwide, developed countries have a higher overall incidence rate and a three-fold higher age-standardized rate [4]. In Western Europe, the incidence rate is 89.7 per 100,000 women while in Eastern Africa, the incidence rate is 19.3 per 100,000 women [3]. Although the global incidence rate of breast cancer is increasing, the underlying causes of the disease are still largely unknown. During the 1980s, screening practices, access to mammography, and the use of exogenous estrogens and progestins contributed to the high incidence rates in developed countries, but these factors do not explain the increase in these countries before the 1980s or the increase in countries with low rates of screening and use of hormones [6]. It has been suggested that the increasing incidence is due to a combination of an increase in the prevalence of known risk factors and to new unidentified risk factors [2, 7]. Family history is a risk factor for developing breast cancer (8), but only 5–10 % of breast cancers are associated with the highly penetrant BRCA1 and BRCA2 genes [8]. In contrast to family history, endocrine status is a prominent risk factor for developing breast cancer. Early age at menarche [9, 10], late age at menopause [11, 12], and later age at first full-term pregnancy [13] increase the risk of developing the disease. Exposure to exogenous estrogens and progestins after menopause [1416] and a history of benign breast disease also increase the risk of developing breast cancer. These well established risk factors, i.e., family history, reproductive and menstrual history, and history of benign breast disease, are estimated to account for only about 40 % of breast cancer cases [17]. Childhood exposure to ionizing radiation [1820], adult alcohol consumption [21], and obesity [7, 22, 23] also increase the risk of developing breast cancer. However, these risk factors are unlikely to account for the remaining cases of the disease [2, 7, 24] suggesting that there are still unidentified causes of breast cancer. …
Literatur
1.
Zurück zum Zitat Richie RC, Swanson JO. Breast cancer: a review of the literature. J Insur Med. 2003;35:85–101.PubMed Richie RC, Swanson JO. Breast cancer: a review of the literature. J Insur Med. 2003;35:85–101.PubMed
2.
Zurück zum Zitat Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol. 2005;34:405–12.PubMedCrossRef Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol. 2005;34:405–12.PubMedCrossRef
3.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.PubMedCrossRef Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.PubMedCrossRef
4.
Zurück zum Zitat Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Canc Res. 2004;6:229–39.CrossRef Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Canc Res. 2004;6:229–39.CrossRef
5.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef
6.
Zurück zum Zitat Ursin G, Bernstein L, Pike MC. Breast cancer. In: Doll R, Fraumeni JF, Muir CS, editors. Cancer surveys. Plainview: Cold Spring Harbor Laboratory Press; 1994. p. 241–64. Ursin G, Bernstein L, Pike MC. Breast cancer. In: Doll R, Fraumeni JF, Muir CS, editors. Cancer surveys. Plainview: Cold Spring Harbor Laboratory Press; 1994. p. 241–64.
7.
Zurück zum Zitat Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004;13:220–4.PubMedCrossRef Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004;13:220–4.PubMedCrossRef
8.
Zurück zum Zitat Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.PubMedCrossRef Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.PubMedCrossRef
9.
Zurück zum Zitat Kampert JB, Whittemore AS, Paffenbarger Jr RS. Combined effect of child-bearing, menstrual events, and body size on age-specific breast cancer risk. Am J Epidemiol. 1988;128:962–79.PubMed Kampert JB, Whittemore AS, Paffenbarger Jr RS. Combined effect of child-bearing, menstrual events, and body size on age-specific breast cancer risk. Am J Epidemiol. 1988;128:962–79.PubMed
10.
Zurück zum Zitat Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer. 1981;43:72.PubMedCrossRef Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer. 1981;43:72.PubMedCrossRef
11.
Zurück zum Zitat Lippman ME. Endocrine responsive cancers of man. In: Williams RH, editor. Textbook of endocrinology. Philadelphia: W.B.Saunders; 1985. p. 1309–26. Lippman ME. Endocrine responsive cancers of man. In: Williams RH, editor. Textbook of endocrinology. Philadelphia: W.B.Saunders; 1985. p. 1309–26.
12.
Zurück zum Zitat Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk? Cancer. 1985;56:1206.PubMedCrossRef Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk? Cancer. 1985;56:1206.PubMedCrossRef
13.
Zurück zum Zitat MacMahon B, Cole P, Brown J. Etiology of human breast cancer: a review. J Natl Canc Inst. 1973;50:21. MacMahon B, Cole P, Brown J. Etiology of human breast cancer: a review. J Natl Canc Inst. 1973;50:21.
14.
Zurück zum Zitat Hoover R, Gray Sr LA, Cole P, MacMahon B. Menopausal estrogens and breast cancer. N Engl J Med. 1976;295:401–5.PubMedCrossRef Hoover R, Gray Sr LA, Cole P, MacMahon B. Menopausal estrogens and breast cancer. N Engl J Med. 1976;295:401–5.PubMedCrossRef
15.
Zurück zum Zitat Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Canc Inst. 1998;90:1292–9.CrossRef Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Canc Inst. 1998;90:1292–9.CrossRef
16.
Zurück zum Zitat Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Canc Inst. 1995;87:190–7.CrossRef Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Canc Inst. 1995;87:190–7.CrossRef
17.
Zurück zum Zitat Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Canc Inst. 1995;87:1681–5.CrossRef Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Canc Inst. 1995;87:1681–5.CrossRef
18.
Zurück zum Zitat Boice Jr JD, Miller RW. Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology. 1999;59:227–33.PubMedCrossRef Boice Jr JD, Miller RW. Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology. 1999;59:227–33.PubMedCrossRef
19.
Zurück zum Zitat Land CE. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. JAMA. 1995;274:402–7.PubMedCrossRef Land CE. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. JAMA. 1995;274:402–7.PubMedCrossRef
20.
Zurück zum Zitat Tokunaga M, Land CE, Yamamoto T, Asano M, Tokuoka S, Ezaki H, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1980. Radiat Res. 1987;112:243–72.PubMedCrossRef Tokunaga M, Land CE, Yamamoto T, Asano M, Tokuoka S, Ezaki H, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1980. Radiat Res. 1987;112:243–72.PubMedCrossRef
21.
Zurück zum Zitat Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst. 2001;93:710–5.PubMedCrossRef Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst. 2001;93:710–5.PubMedCrossRef
22.
Zurück zum Zitat Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987–1989. Am J Epidemiol. 1996;143:985–95.PubMedCrossRef Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987–1989. Am J Epidemiol. 1996;143:985–95.PubMedCrossRef
23.
Zurück zum Zitat International Agency for Research on Cancer. Weight control and physical activity. Lyon: IARC Press; 2002. International Agency for Research on Cancer. Weight control and physical activity. Lyon: IARC Press; 2002.
24.
Zurück zum Zitat Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Canc Inst. 1993;85:892–7.CrossRef Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Canc Inst. 1993;85:892–7.CrossRef
25.
Zurück zum Zitat Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996;104:938–67.PubMedCrossRef Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996;104:938–67.PubMedCrossRef
26.
Zurück zum Zitat Daniel CW, Silberstein GB. Postnatal development of the rodent mammary gland. In: Neville MC, Daniel CW, editors. The mammary gland. New York: Plenum Press; 1987. p. 3–36. Daniel CW, Silberstein GB. Postnatal development of the rodent mammary gland. In: Neville MC, Daniel CW, editors. The mammary gland. New York: Plenum Press; 1987. p. 3–36.
27.
Zurück zum Zitat Kenney NJ, Smith GH, Lawrence E, Barrett JC, Salomon DS. Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland. J Biomed Biotechnol. 2001;1:133–43.PubMedCrossRef Kenney NJ, Smith GH, Lawrence E, Barrett JC, Salomon DS. Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland. J Biomed Biotechnol. 2001;1:133–43.PubMedCrossRef
Metadaten
Titel
Preface
verfasst von
Mary Beth Martin
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Journal of Mammary Gland Biology and Neoplasia / Ausgabe 1/2013
Print ISSN: 1083-3021
Elektronische ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-013-9276-6

Weitere Artikel der Ausgabe 1/2013

Journal of Mammary Gland Biology and Neoplasia 1/2013 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.